LMR Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.12M | Buy |
+2,231
| New | +$1.07M | ﹤0.01% | 1033 |
|
|
2025
Q4 | – | Sell |
-2,767
| Closed | -$1.56M | – | 1733 |
|
|
2025
Q3 | $1.34M | Sell |
2,767
-2,174
| -44% | -$1.01M | 0.01% | 847 |
|
|
2025
Q2 | $2M | Buy |
4,941
+3,536
| +252% | +$1.48M | 0.01% | 638 |
|
|
2025
Q1 | $699K | Sell |
1,405
-1,427
| -50% | -$773K | 0.01% | 854 |
|
|
2024
Q4 | $1.47M | Sell |
2,832
-10,158
| -78% | -$5.58M | 0.01% | 674 |
|
|
2024
Q3 | $8.04M | Buy |
12,990
+3,404
| +36% | +$2.02M | 0.06% | 255 |
|
|
2024
Q2 | $5.3M | Buy |
+9,586
| New | +$5.49M | 0.04% | 315 |
|
|
2024
Q1 | – | Sell |
-7,677
| Closed | -$4.31M | – | 1312 |
|
|
2023
Q4 | $4.07M | Buy |
+7,677
| New | +$3.72M | 0.05% | 350 |
|
|
2022
Q2 | – | Sell |
-1,347
| Closed | -$796K | – | 1465 |
|
|
2022
Q1 | $796K | Sell |
1,347
-190
| -12% | -$109K | 0.01% | 889 |
|
|
2021
Q4 | $1.03M | Buy |
+1,537
| New | +$960K | 0.01% | 677 |
|
|
2021
Q1 | – | Sell |
-2,291
| Closed | -$1.07M | – | 1055 |
|
|
2020
Q4 | $1.07M | Buy |
+2,291
| New | +$1.07M | 0.02% | 274 |
|
|
2020
Q3 | – | Sell |
-3,206
| Closed | -$1.16M | – | 626 |
|
|
2020
Q2 | $1.16M | Buy |
+3,206
| New | +$1.07M | 0.03% | 338 |
|
|
2020
Q1 | – | Sell |
-968
| Closed | -$314K | – | 435 |
|
|
2019
Q4 | $314K | Buy |
+968
| New | +$294K | ﹤0.01% | 350 |
|
|
2019
Q3 | – | Sell |
-9,808
| Closed | -$2.88M | – | 515 |
|
|
2019
Q2 | $2.88M | Buy |
+9,808
| New | +$2.7M | 0.1% | 96 |
|
|
2018
Q3 | – | Sell |
-3,597
| Closed | -$745K | – | 496 |
|
|
2018
Q2 | $745K | Sell |
3,597
-4,984
| -58% | -$1.06M | 0.04% | 212 |
|
|
2018
Q1 | $1.63M | Hold |
8,581
| – | – | 0.17% | 115 |
|
|
2017
Q4 | $1.63M | Buy |
+8,581
| New | +$1.64M | 0.17% | 115 |
|
|
2017
Q3 | – | Sell |
-11,615
| Closed | -$2.03M | – | 538 |
|
|
2017
Q2 | $2.03M | Buy |
+11,615
| New | +$1.95M | 0.13% | 170 |
|
|
2017
Q1 | – | Sell |
-8,677
| Closed | -$1.23M | – | 474 |
|
|
2016
Q4 | $1.23M | Buy |
+8,677
| New | +$1.28M | 0.19% | 122 |
|
|
2016
Q3 | – | Sell |
-4,390
| Closed | -$648K | – | 477 |
|
|
2016
Q2 | $648K | Buy |
+4,390
| New | +$648K | 0.1% | 251 |
|
|
2016
Q1 | – | Sell |
-8,097
| Closed | -$1.15M | – | 423 |
|
|
2015
Q4 | $1.15M | Buy |
+8,097
| New | +$1.08M | 0.37% | 53 |
|
Other funds holding TMO
LMR Partners's TMO Position: Q2 2026 in Review
LMR Partners opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 2,231 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #1033 among its holdings. This is a return to the name: LMR Partners previously reported a position in TMO as recently as Q3 2025.
LMR Partners first reported a position in TMO in Q4 2015 and has held it in 21 quarters since. The position peaked at $8.04M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- LMR Partners held 2,231 shares of Thermo Fisher Scientific worth $1.12M as of Q2 2026.
- Thermo Fisher Scientific was a new LMR Partners position in Q2 2026.
- Thermo Fisher Scientific made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1033 holding.
- LMR Partners first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 21 quarters since.
- LMR Partners's Thermo Fisher Scientific position peaked at $8.04M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.